Replies to post #385877 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

That's revisionist history (depending on when you mean when you say "prior to covid").

You cited Sept 2020 that was six months into the COVID hype train and the 10s of millions in volume + the surge to $0.60 on RBL data. Go back another 9 months. You'll see roughly the figured I referenced. I can't load EDGAR right now.

"Recall prior to COVID we had $600K cash with $7M in liabilities. We had no way forward at that point for the other indications."
My facts..annd the Company''s facts are different than your facts. He had ways forward and he made a choice. So far, when financing has been accessible, his choices haven't had positive results.

We were engaging Locust Walk (a second time?) for a deal before the hopeful COVID hype started. We were probably looking at a buyout or licensing deal with terms similar to B-UP just scaled up a few times for B-OM. It wasn't going to be good. Just like it won't be good if we have to return to that avenue.

Go IPIX!

[noretreat]

and, of course, there is the problem of using an antibiotic to treat a viral infection....